To investigate the regulation of the human fatty acid synthase gene by the thyroid hormone triiodothyronine, various constructs of the human fatty acid synthase promoter and the luciferase reporter gene were transfected in combination with plasmids expressing the thyroid hormone and the retinoid X receptors in HepG2 cells. The reporter gene was activated 25-fold by the thyroid hormone in the presence of the thyroid hormone receptor. When both the thyroid hormone and the retinoid X receptors were expressed in HepG2 cells, there was about a 100-fold increase in reporter gene expression. 5-Deletion analysis disclosed two thyroid hormone response elements, TRE1 (nucleotides ؊870 to ؊650) and TRE2 (nucleotides ؊272 to ؊40), in the human fatty acid synthase promoter. The presence of thyroid hormone response elements in these two regions of the promoter was confirmed by cloning various fragments of these two regions in the minimal thymidine kinase promoter؊luciferase reporter gene plasmid construct and determining reporter gene expression. The results of this cloning procedure and those of electrophoretic mobility shift assays indicated that the sequence GGGTTAcgtcCGGTCA (nucleotides ؊716 to ؊731) represents TRE1 and that the sequence GGGTCC (nucleotides ؊117 to ؊112) represents TRE2. The sequence of TRE1 is very similar to the consensus sequence of the thyroid hormone response element, whereas the sequence of TRE2 contains only a half-site of the thyroid hormone response element consensus motif because it lacks the direct repeat. The sequences on either side of TRE2 seem to inf luence its response to the thyroid hormone and retinoid X receptors.
In animal tissues, the multifunctional enzymes acetyl-CoA carboxylase (EC 6.4.1.2) and fatty acid synthase (FAS; EC 2.3.1.85) are required for the de novo synthesis of fatty acids (1, 2) . Acetyl-CoA carboxylase catalyzes the synthesis of malonylCoA from acetyl-CoA and HCO 3 Ϫ in the presence of ATP. FAS catalyzes the synthesis of long-chain fatty acids from acetylCoA and malonyl-CoA in the presence of NADPH (1, 2) . Recently, we cloned the cDNA coding for the human FAS and determined its sequence (3) . Analysis of this sequence showed that FAS protein sequences are conserved across species, suggesting that multifunctional eukaryotic FASs evolved from the monofunctional enzymes of FAS complexes of prokaryotic origin.
To understand the regulation of human FAS, we measured the FAS mRNA levels in various normal human tissues (3) . The results showed that FAS mRNA exists at very low levels in most tissues and at very high levels in lipogenic tissues such as liver, lung, and brain (3) . The regulation of animal FAS by diet and hormones is well established (1, 4) . Feeding a carbohydrate-rich diet for 2 days to rats or chickens after fasting them for 2 days increases the synthesis of FAS. This procedure has been used to enrich the amount of FAS in the livers of these animals before the enzyme is isolated (1, 2) . Insulin and the thyroid hormone triiodothyronine (T 3 ) increase FAS transcription, whereas glucagon decreases it (4) (5) (6) (7) (8) . T 3 -induced gene expression involves activation of the thyroid hormone receptor (TR) to form a heterodimer with the retinoid X receptor (RXR). This heterodimer (TR͞RXR) binds to the well-characterized thyroid hormone response elements (TREs) and promotes transcription (9) (10) (11) (12) . The consensus TRE sequence (A͞G)GGTCANNNN(A͞G)GGT-CA, called DR4, contains a direct repeat that is separated by four nucleotides (9) . There are other sequence motifs that are known to function as well as TREs (10) (11) (12) . These motifs include ER6 (TGCCTTNNNNNNAAGGCA) (10), a palindrome called IR0 (AGGTCATGACCT) (11) , and an RII enhancer, specifically a DR4 half-site that lacks the direct repeat (12) . Although regulation of gene expression by T 3 can be demonstrated in primary cell cultures of target tissues (4, 6) , most of the cultured cell lines do not respond to T 3 because they lack TR. To achieve such a response, the cells must be transfected with the expression plasmids of these receptors (4).
We reported earlier that the human FAS gene is regulated by two promoters (13) . Promoter I is 15 times stronger than promoter II, which is located in intron I (13) . Herein, we show that only human FAS promoter I is regulated by T 3 and that two TREs are involved in this regulation.
MATERIALS AND METHODS

Materials.
Cell culture media and Lipofectamine were purchased from Life Technologies (Grand Island, NY). Charcoal-treated fetal bovine serum was purchased from Cocalico Biologicals (Reamstown, PA). Ming-Jer Tsai (Department of Cell Biology, Baylor College of Medicine) provided the pRSVhTR␤ and pRSV-mRXR␤ plasmids for expressing human TR and mouse RXR, respectively, in animal cell lines under the control of the Rous sarcoma virus (RSV) promoter and the pT7␤hTR␤ and pT7␤mRXR␤ plasmids for in vitro transcription and translation of the same receptor proteins (14, 15) . The minimal thymidine kinase promoterϪluciferase reporter gene plasmid (TK-Luc) was a gift from Anne Gambel (Department of Cell Biology, Baylor College of Medicine). The mouse TR␤ monoclonal antibodies, polyclonal RXR␤ antibodies, and the double-stranded consensus TRE oligonucleotide DR4 were purchased from Santa Cruz Biotechnology. The sources of all the other chemicals, radioactive materials, and DNAmodifying enzymes were as described before (13) . The human FASluciferase reporter gene plasmids LC9, LC9-1, LC9-2, LC9-3,  LC11 , and LC204 were constructed as described previously (13) . Plasmid LC9-6 was generated by cloning a PCR-derived fragment of human FAS (nucleotides Ϫ116 to ϩ56) in the luciferase vector pXP-1. Plasmids TKϪ272͞Ϫ40, TKϪ272͞ Ϫ67, TKϪ272͞Ϫ116, and TKϪ870͞Ϫ650, which contained fragments of human FAS promoter I in TK-Luc, were generated either by cloning appropriate PCR fragments from human FAS promoter I or by using available restriction sites. Plasmids TK-DR4, TK-TRE1, TKϪ121͞Ϫ87, TKϪ128͞Ϫ103,  TKϪ133͞Ϫ87 , and TKϪ133͞Ϫ107 were generated by cloning the appropriate synthetic oligonucleotides in TK-Luc by using blunt-end ligation.
Construction of Reporter Gene Plasmids.
Cell Culture and Transfection. HepG2 cells were grown in DMEM supplemented with 10% fetal bovine serum, 100 units͞ml penicillin, and 100 g͞ml streptomycin. For the transfection experiments, the cells were cultured for 16 hr in DMEM containing 10% charcoal-treated serum and maintained in the same medium during and after transfection. The transfection procedures were performed according to the manufacturer's recommendations by using 5 l of Lipofectamine and the amounts of plasmid DNAs indicated below. Cells (2 ϫ 10 5 ) were seeded in each well of 6-well culture plates and transfected with Lipofectamine complexes containing 0.5 g each of plasmids pRSV-hTR␤ and pRSV-mRXR␤ and the luciferase reporter gene constructs and 0.2 g of pCMV-␤-gal (␤-galactosidase under the control of a cytomegalovirus promoter). The medium was changed after 16 hr, and T 3 was added to a final concentration of 10 Ϫ6 M. The cells were harvested after 48 hr, and the ␤-galactosidase and luciferase activities were determined as described previously (13) . For normalizing the transfection efficiencies, the luciferase activity was divided by the ␤-galactosidase activity and the reporter gene expression was expressed as relative luciferase units.
In Vitro Transcription and Translation. The pT7hTR␤ and pT7 mRXR␤ plasmids (2 g each in a total volume of 20 l) were used as templates to synthesize the TR and RXR proteins by using a reticulocyte transcription and translation kit (Promega). To ensure that nonradioactive receptor proteins have been synthesized, parallel transcription and translation reactions were performed with [ 35 S]methionine, and the radioactive proteins were analyzed by SDS͞PAGE and detected by autoradiography. The reticulocyte lysates incubated in the absence of template DNA were used as controls in electrophoretic mobility-shift assays (EMSAs).
EMSA. The in vitro-synthesized TR and RXR (1 l each) proteins were incubated for 15 min at room temperature with 32 P-labeled DNA templates (20,000 cpm) and 2 g of poly(dIdC) in 15 l of a reaction mixture containing 10 mM Hepes (pH 7.9), 50 mM KCl, 1 mM MgCl 2 , 1 mM DTT, 10% glycerol, and 10 Ϫ6 M T 3 . In competition assays, nonradioactive probes or DR4 oligonucleotides were added to the reaction mixture in 5-to 50-fold excess of the radioactive probe. To perform supershift analysis, either anti-TR or anti-RXR antibodies were added to the reaction mixture and incubated for an additional 10 min. The DNA-protein complexes that were formed were analyzed on a 5% polyacrylamide gel by using Tris-borate-EDTA buffer (45 mM Tris͞44.5 mM borate͞1 mM EDTA, pH 8.0) (16) at room temperature and were detected by autoradiography.
RESULTS AND DISCUSSION
Human FAS Promoter I Responds to T 3 . We reported earlier that human FAS is regulated by two promoters (13) . To determine which of the two promoters of the human FAS gene responds to T 3 in HepG2 cells, we performed transient transfection assays with the promoter I plasmid LC9 and the promoter II plasmid LC208 (13) . As shown in Fig. 1 , the FIG. 1. Activation of human FAS promoter I by T3. The luciferase reporter gene constructs LC9 (promoter I) and LC208 (promoter II) were constructed as described earlier (13) and were tested for their response to T3 as described in Materials and Methods. HepG2 cells were transfected with LC9 or LC208 together with receptor plasmids pRSV-hTR␤ and pRSV-mRXR␤ alone or in combination. The pCMV-␤-gal plasmid was cotransfected in all experiments, and the ␤-galactosidase activity obtained was used to normalize transfection efficiencies. To serve as a control, the pRSV plasmid that lacked the receptor coding sequences was transfected instead of the pRSV-hTR␤ and pRSV-mRXR␤ plasmids (represented as ''none''). 1 ). Although LC9 did not respond to T 3 when cotransfected with pRSV-mRXR␤ alone, its response to T 3 increased by Ϸ100-fold when it was cotransfected with both pRSV-hTR␤ and pRSV-mRXR␤ ( Fig. 1 ). LC208 did not respond significantly to T 3 , even when the plasmid was cotransfected with both pRSV-hTR␤ and pRSV-mRXR␤ ( Fig. 1) . These results indicated that human FAS promoter I, but not promoter II, is regulated by T 3 and that this regulation is mediated by means of the TR͞RXR heterodimer. Furthermore, in the absence of T 3 , reporter gene expression was reduced more in the cells transfected with LC9 and the TR-expression plasmid than in the cells transfected with LC9 alone (Fig. 1) . This reduced expression probably results from the repression by TR of the basal promoter activity of TREcontaining promoters in the absence of T 3 (17, 18) . The 25-fold increase in reporter gene expression in the presence of T 3 suggests that either RXR or some other TR partner present in HepG2 cells is responsible for this induction.
Localization of TRE Elements in Human FAS Promoter I. To identify the location of TREs in human FAS promoter I, several 5Ј-deletion constructs of the promoter I-luciferase reporter gene construct were tested for their expression in HepG2 cells. As shown in Table 1 , all of the reporter gene plasmids except LC9-6(Ϫ116) responded to T 3 in the presence of TR or TR͞RXR. In the absence of T 3 , TR reduced the basal promoter activity of all the reporter plasmids except LC9-6(Ϫ116) (data not shown). These results suggested that LC9-6(Ϫ116) lacks a functional TRE (17, 18) . The 5Ј-deletion constructs, however, varied in their response to T 3 in the presence of TR alone and in the presence of both TR and RXR. The reporter gene LC9(Ϫ870) showed a response to T 3 that was 4 times higher than that of LC11(Ϫ1900) in the presence of TR ( Table 1 ). The T 3 response of LC11(Ϫ1900) was stimulated another 7-fold when both TR and RXR were expressed in HepG2 cells, whereas LC9(Ϫ870) showed only an additional 4-fold increase. These results suggested that the sequence upstream of nucleotide Ϫ870 influenced the TRE function of human FAS promoter I. Deletion of sequences between nucleotides Ϫ870 and Ϫ650 resulted in a drastic difference in the relative T 3 response of the reporter gene activity in the presence of TR and TR͞RXR (Table 1 , LC9 and LC9-1). The reporter genes LC9-1(Ϫ650), LC9-2(Ϫ361), and LC9-3(Ϫ272) showed only a 2-to 3-fold increase in T 3 response in the presence of TR, as compared with the 21-fold increase in response observed with LC9, and an additional 10-fold increase in T 3 response in the presence of TR͞RXR (Table 1) . The LC9-6(Ϫ116) reporter gene showed no significant increase in T 3 response in the presence of TR but showed a 4-fold increase in reporter gene expression when both TR and RXR were expressed in the HepG2 cells. These results suggested that various sequences in human FAS promoter I influence the binding of TR͞RXR to TRE. Despite the differences in the way the 5Ј-deletion constructs respond to T 3 in the presence of TR alone or in the presence of both TR and RXR, it appears that there are two TREs in promoter I. One of these TREs (TRE1) is located in the sequence between nucleotides Ϫ870 and Ϫ650, and the second one (TRE2) is located in the sequence between nucleotides Ϫ272 and ϩ56. The response of LC9-3(Ϫ272), which contains TRE2, to T 3 in the presence of both TR and RXR was Ϸ20-30% of that of LC9(Ϫ870), which contains both TRE1 and TRE2. Therefore, based on the 5Ј-deletion analysis, TRE1 is 2-to 3-fold more efficient than TRE2 in eliciting a T 3 response in the presence of both TR and TXR.
To further confirm the existence of the two TREs in human FAS, we cloned the human FAS promoter segments that contain TRE1 (nucleotides Ϫ870 through Ϫ650) and TRE2 (nucleotides Ϫ272 through Ϫ40 and Ϫ272 through Ϫ67) in TK-Luc, thereby generating TK-LucϪ870͞Ϫ650, TKLucϪ272͞Ϫ40, and TK-LucϪ272͞Ϫ67, respectively. As shown in Fig. 2 , TK-LucϪ870͞Ϫ650 showed an increase in T 3 response of about 25-fold in the presence of TR and of 75-fold in the presence of both TR and RXR. The T 3 response of TK-LucϪ272͞Ϫ40 and TK-LucϪ272͞Ϫ67 increased 2-fold and 4-fold, respectively, in the presence of TR and 28-fold and 53-fold, respectively, in the presence of TR͞RXR (Fig. 2) . These results confirmed those obtained in the 5Ј-deletion analysis, namely that there are two T 3 response elements in human FAS promoter I ( Table 1) .
The basal promoter activity of TKϪ272͞Ϫ40 in the absence of receptor expression plasmids was found to be severalfold higher than that of TKϪ272͞Ϫ67 (Fig. 2) . The 27-bp sequence between nucleotides Ϫ67 and Ϫ40 is identical to the sequence that has been shown to contain the insulin response element in the rat FAS promoter (8, 13) . However, we did not observe insulin-mediated promotion of the T 3 response when we transfected HepG2 cells with any of the reporter gene constructs we used (Table 1) or with TK-LucϪ272͞Ϫ40 (data not shown). The insulin response element present in the 27-bp sequence is an E-box motif (CATGTG at nucleotide Ϫ57) and binds trans-activating factors (USF1 and USF2) that contains the basic helix-loop-helix motif (19) . It is possible, however, that some other trans-activating factor that binds to this sequence enhances the basal promoter activity of the TKϪ272͞Ϫ40 construct (Fig. 2) .
EMSAs Using TR and RXR Proteins. These assays were performed with in vitro-synthesized TR and RXR proteins as described under Materials and Methods. The reticulocyte lysate or the lysate containing only TR did not retard the electro- A series of 5Ј deletions were tested for their response to T3. The experimental conditions are as described in the legend to Fig. 1 phoretic mobility of the 32 P-labeled 220-bp human FAS promoter fragment (Ϫ870 through Ϫ650) containing TRE1 (Fig.  3) . Similar results were obtained by using RXR alone (data not shown). When the DNA probe was incubated with a mixture of lysates containing TR and RXR, however, a slow-moving band (Fig. 3) was observed. The unlabeled probe fragment competed for this complex formation (slow-moving band) and essentially eliminated it at a 50-fold excess of the radioactive probe (Fig. 3) . The electrophoretic mobility of the slowmoving band was further retarded when anti-hTR␤ antibodies were added to the reaction mixture after the receptor protein-DNA complexes (supershifted bands, Fig. 3 ) had been formed. This supershifting of the TRE-receptor complexes confirmed that these complexes do contain TR.
To determine the location of TRE1, we used several synthetic double-stranded oligonucleotides (Ϸ30 bp each), which covered the entire nucleotide sequence of Ϫ870 through Ϫ650, as unlabeled competitors for the 32 P-labeled 220-bp human FAS promoter fragment (Ϫ870 through Ϫ650) in an EMSA. Based on these experiments (data not shown), we found that a double-stranded oligonucleotide with the sequence GGG-GATGCGCTGCGATGACCGGCAGTAACCCCGG (nucleotides Ϫ747 through Ϫ713) competed with the radioactive probe. The complementary strand of this oligonucleotide (CCGGGGTTACTGCCGGTCATCGCAGCGCATCCCC; nucleotides Ϫ713 through Ϫ747) contained a TRE motif (GGGTTActgcCGGTCA) that is similar to the consensus TRE sequence (A͞GGGTCANNNNA͞GGGTCA) (9) , which has a direct repeat separated by four nucleotides (DR4). In EMSAs, the double-stranded oligonucleotide (Ϫ747 through Ϫ718) that contained TRE1 was found to behave like a TRE (Fig. 4A) . TR and RXR are both required for the mobility shift of this fragment (Fig. 4A) . In addition, the consensus DR4 double-stranded oligonucleotide A͞GGGTCANNNNA͞ GGGTCA competed effectively with the binding of the probe to the receptor proteins (Fig. 4A) . Because the complementary sequence Ϫ716 through Ϫ731 is very similar to the DR4 consensus sequence we considered this sequence to be TRE1.
When we used a truncated synthetic double-stranded oligonucleotide probe that contained the Ϫ747 through Ϫ718 sequence instead of the Ϫ747 through Ϫ713 sequence (Fig.  4A) , none of the lanes contained a shifted band (Fig. 4B) . We considered the faint band present in all the lanes, except those to which the nonradioactive competitor was added, to be nonspecific because it was present even in the first lane, which contained no receptor proteins (Fig. 4B) . These results suggest that in the complementary sequence GGGTTACTGCCG-GTCA (nucleotides Ϫ716 through Ϫ731) the first two G residues are critical for the binding of the receptor to this TRE1.
To further confirm our findings, we constructed TK-TRE1, which contained nucleotides Ϫ747 through Ϫ713. TK-TRE1 showed a 10-fold response to T 3 in the presence of TR and a 40-fold response in the presence of both TR and RXR (Fig. 5) . A TK-DR4 construct, which contained the consensus DR4 sequence, showed about a 4-fold response to T 3 in the presence of TR and a 25-fold response in the presence of TR and RXR. These results confirmed that this sequence functions in vivo as TRE and that its activity is comparable with that of the consensus TRE construct TK-DR4 (Fig. 5) .
FIG. 2. Confirmation of the presence of two TREs in human FAS
promoter I by using a heterologous promoter. The region of human FAS promoter I that contains TRE1 (nucleotides Ϫ870 through Ϫ650) was cloned in the TK-Luc vector, thereby generating TKϪ870͞Ϫ650. Similarly, the TRE2-containing cloning regions Ϫ272 through Ϫ67 and Ϫ272 through Ϫ40 in the TK-Luc vector generated constructs TKϪ272͞Ϫ67 and TKϪ272͞Ϫ40, respectively. These reporter constructs were tested for their activity in HepG2 cells as described in the legend of Fig. 1 and in Materials and Methods. Determining the Location of TRE2. Based on the 5Ј-deletion analysis (Table 1 ) and the TK-Luc cloning procedures (Fig. 2) , we determined the location of TRE2 to be between nucleotides Ϫ272 and Ϫ67. Although we could not identify a typical DR4-type TRE sequence in this region, we found two half-site sequences that both contained GGGTCC. One of the half-site sequences is located between nucleotides Ϫ174 and Ϫ169 and the other between nucleotides Ϫ117 and Ϫ112. Because the 5Ј-deletion construct LC9-172, which contained sequences from nucleotides Ϫ172 through ϩ56, showed an appreciable T 3 response, we concluded that the half-site sequence at nucleotide Ϫ117 may function as TRE2 and not the one located at nucleotide Ϫ174 (data not shown). To confirm the functionality of the TRE half-site located at nucleotide Ϫ117, we cloned several fragments upstream and downstream of this TRE in TK-Luc vector. As shown in Table  2 , all the TK constructs that contained TRE2 exhibited a 60-to 80-fold increase in reporter gene expression in the presence of both T 3 and TR and only an additional 2.5-fold increase in the presence of both TR and RXR. The constructs TKϪ121͞ Ϫ87 and TKϪ133͞Ϫ107 showed a similar T 3 response, suggesting that TRE2 is located between nucleotides Ϫ121 and Ϫ107 ( Table 2 ). The TRE2 motif located in this region at nucleotide Ϫ117 is similar to the RII enhancer, a half-site TRE of the major histocompatibility complex class I genes that activates gene expression in response to retinoic acid (12) . The results shown in Table 2 and in Fig. 2 also suggest that sequences upstream of nucleotide Ϫ133 on the 5Ј side and downstream of nucleotide Ϫ87 could influence the way TRE2 responds to T 3 and its receptors.
To determine whether this half-site TRE sequence binds the TR͞RXR heterodimer and whether the neighboring sequences influence the binding of TR͞RXR, we performed an EMSA using a double-stranded oligonucleotide (CGGCGG-CGGCGCGCCGGGTCCCGGGGCGCAGCCCCGACGC-TCATTGG) as a labeled probe and various mutant oligonucleotides as nonradioactive competitors. The probe fragment was shifted (i.e., retarded) only in the presence of both TR and RXR. Adding anti-hTR␤ antibodies caused a supershift. The unlabeled probe oligonucleotides and the DR4 oligonucleotides competed for the binding of the TR͞RXR complex to the labeled probe (Fig. 6) . Among the mutant oligonucleotides, the one containing AAATCC instead of GGGTCC did not compete for the binding of TR͞RXR, suggesting that the first three Gs in the sequence GGGTCC of TRE2 are critical for TRE2 function (Fig. 6 ). This result is consistent with the observation that LC9-6(Ϫ116), a FAS promoter reporter gene construct that lacks the first G of the GGGTCC sequence, did not respond to T3 (Table 1) . When the five nucleotides within the immediate 5Ј or 3Ј portion of the GGGTCC sequence in Various regions of the human FAS promoter that contain TRE2 were amplified by using the polymerase chain reaction and were cloned in minimal TK-Luc vector. HepG2 cells were transfected with these plasmids, and their response to T3 was assessed. The experimental conditions used were as described for Table 1 the TR2 synthetic oligonucleotide shown above were converted to Ts, the resulting probe competed as well as the unlabeled wild-type TRE2 probe (Fig. 6) . These results suggest that the five nucleotides on either side of TRE2 do not influence its binding to TR͞RXR. Consequently, the core motif GGGTCC functions as TRE2.
In conclusion, promoter I of the human FAS gene is strongly activated by T 3 when HepG2 cells are transfected with plasmids expressing TR or RXR. Under the same experimental conditions, promoter II of the human FAS gene does not respond to T 3 . There are two regions in promoter I (nucleotides Ϫ870 to Ϫ650 and Ϫ272 to Ϫ67) that contain TRE and independently activated hFAS-promoter-Luc and TK-Luc reporter genes in the presence of T 3 . The complementary sequence of the nucleotides between Ϫ716 and Ϫ731, which contains 5ЈGGGTTActgcCCGGTCA, is a variant of DR4 consensus sequences and is considered to be TRE1 because it imparts a T 3 response to the TK-Luc reporter gene. Further confirmation that this sequence is TRE1 was achieved by EMSAs, which showed that neither TR nor RXR alone bind to the probe containing TRE1 and that both receptor proteins are required for the mobility shift. In addition, the TRE1-TR͞RXR complex is supershifted by adding anti-hTR␤ antibodies to the assay mixture. The sequence of nucleotides Ϫ669 through Ϫ650 in the rat FAS promoter (20) is identical to the TRE1 sequence. Three nucleotides on the 5Ј side and two nucleotides on the 3Ј side are also conserved. Even though the rest of the sequence on either side of the sequence is not conserved, this sequence in the rat FAS promoter corresponds to TRE1 in human FAS.
Based on the 5Ј-deletion analysis and the cloning of various fragments in the TK-Luc reporter gene, TRE2 is located between nucleotides Ϫ121 and Ϫ102. The EMSAs performed with various mutant oligonucleotides identified a half-site sequence, GGGTCC, which is located between nucleotides Ϫ117 and Ϫ112. This half-site TRE is similar to the RII enhancer as described above (12) . The TRE2 sequence is also conserved in both human and rat FAS promoters (13, 20) . Interestingly, the various TRE2-containing DNA fragments that were cloned in the reporter gene constructs used in these studies responded differently to T 3 in the presence of TR alone and in the presence of TR͞RXR. It is possible that some trans-activating factors that bind to the sequences upstream and downstream of the TRE2 sequence may influence the way in which TRE2 binds TR and endogenous RXR. These results clearly demonstrate the role of T 3 in the regulation of human FAS.
